Evaluation status available after sign-in
About the journal
Oncogene is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 5,490 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1476-5594 · 0950-9232
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 5,490 EUR
- Declared peer-review model
- peer_review
- Official website
- http://www.nature.com/onc
Index listings
- MEDLINE · 1987-01-01
- PUBMED · 1995-01-05
- Indexing
- MEDLINE · PUBMED
- APC
- 5,490 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 210 days received→accepted — computed from PubMed (n=85)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
19611
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
424
i10-index
17531
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 85%
- ORCID iDs in current deposits
- 91%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 8711562
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Protein Kinase Regulation and GTPase Signaling
- Cell death mechanisms and regulation
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Show all subjects (75)
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- Cancer Cells and Metastasis
- DNA Repair Mechanisms
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Cancer-related gene regulation
- Cancer-related gene regulation
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- PI3K/AKT/mTOR signaling in cancer
- Mechanisms of cancer metastasis
- RNA Research and Splicing
- RNA Research and Splicing
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Epigenetics and DNA Methylation
- TGF-β signaling in diseases
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Protein Kinase Regulation and GTPase Signaling
- Ubiquitin and proteasome pathways
- Protein Tyrosine Phosphatases
- Chromatin Remodeling and Cancer
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- Wnt/β-catenin signaling in development and cancer
- Wnt/β-catenin signaling in development and cancer
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Prostate Cancer Treatment and Research
- NF-κB Signaling Pathways
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- MicroRNA in disease regulation
- HER2/EGFR in Cancer Research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Microtubule and mitosis dynamics
- NF-κB Signaling Pathways
- Signaling Pathways in Disease
- Melanoma and MAPK Pathways
- Glioma Diagnosis and Treatment
- Cancer Research and Treatments
- Cancer Research and Treatments
- Wnt/β-catenin signaling in development and cancer
- Protease and Inhibitor Mechanisms
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Hippo pathway signaling and YAP/TAZ
- Melanoma and MAPK Pathways
- Melanoma and MAPK Pathways
- Hippo pathway signaling and YAP/TAZ
- interferon and immune responses
- interferon and immune responses
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ